The London-based Financial Times newspaper said on Monday, without revealing its source, that the bid could be worth USD2.1 billion.
Pliva had earlier been approached by Icelandic generic drug maker Actavis, which offered about USD1.85 billion.
ZAGREB, May 29 (Hina) - Croatian pharmaceutical group Pliva on Monday declined to comment on a newspaper report that US drug maker Barr Pharmaceuticals had made a bid for it, noting that several companies had expressed their interest
in buying the Croatian company.
ZAGREB, May 29 (Hina) - Croatian pharmaceutical group Pliva on
Monday declined to comment on a newspaper report that US drug maker Barr
Pharmaceuticals had made a bid for it, noting that several companies had
expressed their interest in buying the Croatian company.